XML 58 R35.htm IDEA: XBRL DOCUMENT v3.8.0.1
Fair Value Measurements (Tables)
9 Months Ended
Sep. 30, 2017
Fair Value Disclosures [Abstract]  
Fair Value of Assets and Liabilities
The following tables summarize the Company’s assets and liabilities that are measured at fair value on a recurring basis as of September 30, 2017:
 
Fair Value Measurement at Reporting Date Using
(in millions)
Level 1
 
Level 2
 
Level 3
 
Total
Assets:
 
 
 
 
 
 
 
Cash equivalents
$
4.7

 
$

 
$

 
$
4.7

Interest rate swap

 
0.6

 

 
0.6

Liabilities:
 
 
 
 
 
 
 
Contingent consideration

 

 
6.2

 
6.2

Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation
The following table provides a roll-forward of the fair value of recurring Level 3 fair value measurements in the three months ended September 30, 2017 and 2016:
(in millions)
2017
 
2016
Contingent consideration liability, at July 1
$
5.7

 
$
5.0

Issuance of contingent consideration in connection with acquisitions

 

Settlements of contingent consideration liabilities

 

Foreign currency translation
0.4

 
(0.1
)
Total losses included in earnings (a)
0.1

 
0.2

Contingent consideration liability, at September 30
$
6.2

 
$
5.1

(a)
Changes in the fair value of contingent consideration liabilities are included as a component of Acquisition and integration-related expenses within the Condensed Consolidated Statements of Operations.
The following table provides a roll-forward of the fair value of recurring Level 3 fair value measurements in the nine months ended September 30, 2017 and 2016:
(in millions)
2017
 
2016
Contingent consideration liability, at January 1
$
5.1

 
$

Issuance of contingent consideration in connection with acquisitions

 
4.9

Settlements of contingent consideration liabilities

 

Foreign currency translation
0.5

 

Total losses included in earnings (a)
0.6

 
0.2

Contingent consideration liability, at September 30
$
6.2

 
$
5.1

(a)
Changes in the fair value of contingent consideration liabilities are included as a component of Acquisition and integration-related expenses within the Condensed Consolidated Statements of Operations.